Cargando…
Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti-PD-1 Treatment
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257296/ https://www.ncbi.nlm.nih.gov/pubmed/35813096 http://dx.doi.org/10.1097/HS9.0000000000000749 |
| _version_ | 1784741314412150784 |
|---|---|
| author | Drees, Esther E. E. Jauw, Yvonne W. S. van Dijk, Erik Borchmann, Sven Verkuijlen, Sandra A. W. M. Stathi, Phylicia Groenewegen, Nils J. Hijmering, Nathalie J. Berry, Daniella R. A. I. Meershoek, Eric J. Hoogmoed, Danielle Kwakman, Anne Molenaar, Tessa J. Pegtel, Dirk M. Ylstra, Bauke de Jong, Daphne Zijlstra, Josée M. Roemer, Margaretha G. M. |
| author_facet | Drees, Esther E. E. Jauw, Yvonne W. S. van Dijk, Erik Borchmann, Sven Verkuijlen, Sandra A. W. M. Stathi, Phylicia Groenewegen, Nils J. Hijmering, Nathalie J. Berry, Daniella R. A. I. Meershoek, Eric J. Hoogmoed, Danielle Kwakman, Anne Molenaar, Tessa J. Pegtel, Dirk M. Ylstra, Bauke de Jong, Daphne Zijlstra, Josée M. Roemer, Margaretha G. M. |
| author_sort | Drees, Esther E. E. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9257296 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92572962022-07-07 Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti-PD-1 Treatment Drees, Esther E. E. Jauw, Yvonne W. S. van Dijk, Erik Borchmann, Sven Verkuijlen, Sandra A. W. M. Stathi, Phylicia Groenewegen, Nils J. Hijmering, Nathalie J. Berry, Daniella R. A. I. Meershoek, Eric J. Hoogmoed, Danielle Kwakman, Anne Molenaar, Tessa J. Pegtel, Dirk M. Ylstra, Bauke de Jong, Daphne Zijlstra, Josée M. Roemer, Margaretha G. M. Hemasphere Letter Lippincott Williams & Wilkins 2022-07-04 /pmc/articles/PMC9257296/ /pubmed/35813096 http://dx.doi.org/10.1097/HS9.0000000000000749 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nd/4.0/This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0 (https://creativecommons.org/licenses/by-nd/4.0/) , which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. |
| spellingShingle | Letter Drees, Esther E. E. Jauw, Yvonne W. S. van Dijk, Erik Borchmann, Sven Verkuijlen, Sandra A. W. M. Stathi, Phylicia Groenewegen, Nils J. Hijmering, Nathalie J. Berry, Daniella R. A. I. Meershoek, Eric J. Hoogmoed, Danielle Kwakman, Anne Molenaar, Tessa J. Pegtel, Dirk M. Ylstra, Bauke de Jong, Daphne Zijlstra, Josée M. Roemer, Margaretha G. M. Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti-PD-1 Treatment |
| title | Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti-PD-1 Treatment |
| title_full | Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti-PD-1 Treatment |
| title_fullStr | Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti-PD-1 Treatment |
| title_full_unstemmed | Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti-PD-1 Treatment |
| title_short | Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti-PD-1 Treatment |
| title_sort | blood-based monitoring of relapsed/refractory hodgkin lymphoma patients predict responses to anti-pd-1 treatment |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257296/ https://www.ncbi.nlm.nih.gov/pubmed/35813096 http://dx.doi.org/10.1097/HS9.0000000000000749 |
| work_keys_str_mv | AT dreesestheree bloodbasedmonitoringofrelapsedrefractoryhodgkinlymphomapatientspredictresponsestoantipd1treatment AT jauwyvonnews bloodbasedmonitoringofrelapsedrefractoryhodgkinlymphomapatientspredictresponsestoantipd1treatment AT vandijkerik bloodbasedmonitoringofrelapsedrefractoryhodgkinlymphomapatientspredictresponsestoantipd1treatment AT borchmannsven bloodbasedmonitoringofrelapsedrefractoryhodgkinlymphomapatientspredictresponsestoantipd1treatment AT verkuijlensandraawm bloodbasedmonitoringofrelapsedrefractoryhodgkinlymphomapatientspredictresponsestoantipd1treatment AT stathiphylicia bloodbasedmonitoringofrelapsedrefractoryhodgkinlymphomapatientspredictresponsestoantipd1treatment AT groenewegennilsj bloodbasedmonitoringofrelapsedrefractoryhodgkinlymphomapatientspredictresponsestoantipd1treatment AT hijmeringnathaliej bloodbasedmonitoringofrelapsedrefractoryhodgkinlymphomapatientspredictresponsestoantipd1treatment AT berrydaniellarai bloodbasedmonitoringofrelapsedrefractoryhodgkinlymphomapatientspredictresponsestoantipd1treatment AT meershoekericj bloodbasedmonitoringofrelapsedrefractoryhodgkinlymphomapatientspredictresponsestoantipd1treatment AT hoogmoeddanielle bloodbasedmonitoringofrelapsedrefractoryhodgkinlymphomapatientspredictresponsestoantipd1treatment AT kwakmananne bloodbasedmonitoringofrelapsedrefractoryhodgkinlymphomapatientspredictresponsestoantipd1treatment AT molenaartessaj bloodbasedmonitoringofrelapsedrefractoryhodgkinlymphomapatientspredictresponsestoantipd1treatment AT pegteldirkm bloodbasedmonitoringofrelapsedrefractoryhodgkinlymphomapatientspredictresponsestoantipd1treatment AT ylstrabauke bloodbasedmonitoringofrelapsedrefractoryhodgkinlymphomapatientspredictresponsestoantipd1treatment AT dejongdaphne bloodbasedmonitoringofrelapsedrefractoryhodgkinlymphomapatientspredictresponsestoantipd1treatment AT zijlstrajoseem bloodbasedmonitoringofrelapsedrefractoryhodgkinlymphomapatientspredictresponsestoantipd1treatment AT roemermargarethagm bloodbasedmonitoringofrelapsedrefractoryhodgkinlymphomapatientspredictresponsestoantipd1treatment |